When to Stop Taking Progesterone in Pregnancy

Stopping progesterone during pregnancy occurs most often between 10 and 16 weeks when the placenta assumes hormone production, though the exact point depends on the medical reason for supplementation.

Women who receive progesterone after IVF or embryo transfer commonly discontinue it once the placenta takes over, typically around 10 to 12 weeks. Sources note that continuation until week 12 is a frequent protocol because the luteo-placental shift is usually complete by then. Abrupt cessation or gradual tapering both appear in clinical practice; physicians choose the approach based on individual ultrasound findings and hormone levels.

Stopping points for different indications

Guidelines differ according to the purpose of treatment. For women with a history of miscarriage and early bleeding, progesterone is often continued until 16 weeks. This cutoff comes from trials that tested supplementation through the first half of the second trimester. In contrast, women at risk of preterm birth may receive 17-hydroxyprogesterone caproate injections from 16 weeks until 36 weeks.

IVF and assisted reproduction

After IVF, progesterone supports the luteal phase and early implantation. Most programs stop supplementation once the placenta produces adequate levels, which occurs between 10 and 12 weeks. One fertility network states that treatment until approximately week 12 is the most common recommendation, after which the pregnancy proceeds without exogenous hormone. For the next step, read our overview of How Faint Can a Pregnancy Test Line Be.

Miscarriage prevention

NICE guidance supports progesterone use until 16 weeks in women with prior miscarriage and current bleeding. The 16-week mark aligns with the end of the period when the corpus luteum is still the main source of progesterone before full placental takeover. For related context, see our guide to Is White Discharge Before Period a Sign of Pregnancy.

Preterm birth prevention

Weekly intramuscular 17-OHPC is sometimes prescribed from 16–24 weeks until 36 weeks for women with a prior spontaneous preterm birth. Longer courses beyond 12 weeks have been linked to improved neonatal outcomes in observational data, but decisions remain individualized.

Placental takeover and monitoring

The placenta begins producing sufficient progesterone around 10–12 weeks. Until that shift, supplemental progesterone maintains the uterine lining and reduces contractions. Ultrasound confirmation of a viable pregnancy and rising hormone levels help clinicians decide when medication can safely end.

What happens if progesterone is stopped

Discontinuing too early can raise miscarriage risk in supported cycles. Once the placenta functions adequately, stopping does not appear to increase loss rates. No strong evidence shows sudden cessation at the recommended weeks harms an otherwise healthy pregnancy, yet many clinics taper doses to ease patient anxiety.

Key considerations before stopping

• Confirm gestational age and placental function with your obstetrician.
• Review bleeding history or prior preterm birth risk.
• Discuss whether tapering or abrupt stop is preferred in your case.
• Never adjust medication without medical supervision, as individual factors override general timelines.

Progesterone protocols are tailored; the same schedule does not suit every pregnancy. Consultation with the prescribing clinician remains essential for safe discontinuation.

Sources

• The use of progesterone during pregnancy to prevent preterm ...
• Association between the duration of progesterone ... - PMC
• Taking progesterone in early pregnancy - Miscarriage